Fineline Cube

Follow:
14475 Articles
Policy / Regulatory

NHSA Releases Preliminary Review Results for National Reimbursement Drug List Adjustments

Company

Novartis Sets Tentative Date for Sandoz Spin-Off, Targets October 4

Company

Jiangsu Hengrui Pharmaceuticals Reports 9.19% YOY Revenue Growth in H1 2023 Financial Report

Drug

AstraZeneca’s Forxiga Gains New Indication Approval in China for Chronic Heart Failure

CompanyDeals

Hua Medicine Achieves Development Milestone for HuaTangNing with Bayer Agreement

CompanyDrug

MSD’s Welireg Meets Primary Endpoint in Phase III RCC Study but Misses OS Milestone

CompanyDeals

CARsgen Therapeutics Partners with Moderna to Combine CAR-T Therapy with mRNA Cancer Vaccine

CompanyDeals

Simcere Pharmaceutical Group Secures Exclusive Rights to CMAB009 in China

CompanyDeals

Ezisurg Medical Partners partners with Vathin for Global Disposable Endoscope strategic partnership

Company

Fosun Pharma Adjusts Investment Allocation for 2022 Non-Public Offering Projects

CompanyDrug

HutchMed’s Sovleplenib Achieves Primary and Secondary Endpoints in ESLIM-01 Phase III Trial

CompanyDrug

Grand Pharmaceutical Group Initiates Phase I Study for Sepsis Treatment APAD